COVID-19 Vaccine Update

MRNA-1237: This vaccine uses mRNA thats our bodies to make our proteins spike. As a result, antibodies are produced in our system, similar to the ones produced people who had COVID-19. The public will know if the vaccine works in November.

UB-612: This vaccine contains parts of several viral proteins. Phase 1 of this vaccine is being conducted in Taiwan, and phases 2 and 3 will be done in Brazil.

INO-400: This vaccine is delivered into the skin, with electronic pulses from a smart devices. Thankfully, there has not been any serious effects of their vaccine in the volunteers. The FDA has put on hold on the vaccine, however, because of questions about their delivery device.

BNT-162: This mRNA vaccine that was launched in two versions. Both versions caused volunteers to produce T-cells and antibodies, however, the BNT162B2 version caused less side effects. The public is expected to know if the vaccine works in October.